Dr. Reddy's Laboratories, Inc. (RDY)’s Announces the Launch of Ziprasidone Hydrochloride Capsules  
3/5/2012 6:18:04 AM

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Ziprasidone Hydrochloride Capsules, a bioequivalent generic version of Geodon® in the US market on March 2, 2012 following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy’s ANDA for Ziprasidone Hydrochloride Capsules.